Format

Send to

Choose Destination
Genes Cancer. 2012 Mar;3(3-4):226-39. doi: 10.1177/1947601912455322.

The Many Faces of MDM2 Binding Partners.

Author information

1
Department of Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Abstract

Mdm2 is an essential regulator of the p53 tumor suppressor. Mdm2 is modified at transcriptional, post-transcriptional, and post-translational levels to control p53 activity in normal versus stressed cells. Importantly, errors in these regulatory mechanisms can result in aberrant Mdm2 expression and failure to initiate programmed cell death in response to DNA damage. Such errors can have severe consequences as evidenced by tumor phenotypes resulting from amplification at the Mdm2 locus and changes in post-transcriptional and post-translational regulation of Mdm2. Although Mdm2 mediated inhibition of p53 is well characterized, Mdm2 interacts with many additional proteins and also targets many of these for proteosomal degradation. Mdm2 also has E3-ligase independent functions and p53-independent functions that have important implications for genome stability and cancer.

KEYWORDS:

DNA damage; Mdm2; p53; tumorigenesis; ubiquitination

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center